Clinical characteristics and cytogenetics of acute myeloid leukemia patients
| Patient . | Sex/age . | Sample . | Cytogenetics . | Blasts, % . | FAB . |
|---|---|---|---|---|---|
| 1 | M/60 | PB | 46, XY, del(12)(q15q22) | 82.20 | M4 |
| 2 | F/24 | PB | 49, XX, +8, inv(16)(q13q22), +21, +22 | 85.50 | M4 |
| 3 | M/59 | PB | 46, XX, no cytogenetic abnormalities | 86.00 | M4 |
| 4 | M/57 | PB | 46, XX, no cytogenetic abnormalities | 92.00 | M1 |
| 5 | M/34 | PB | 46, XX, multiple cytogenetic abnormalities | 80.00 | M0 |
| Patient . | Sex/age . | Sample . | Cytogenetics . | Blasts, % . | FAB . |
|---|---|---|---|---|---|
| 1 | M/60 | PB | 46, XY, del(12)(q15q22) | 82.20 | M4 |
| 2 | F/24 | PB | 49, XX, +8, inv(16)(q13q22), +21, +22 | 85.50 | M4 |
| 3 | M/59 | PB | 46, XX, no cytogenetic abnormalities | 86.00 | M4 |
| 4 | M/57 | PB | 46, XX, no cytogenetic abnormalities | 92.00 | M1 |
| 5 | M/34 | PB | 46, XX, multiple cytogenetic abnormalities | 80.00 | M0 |
FAB indicates French-American-British staging; PB, peripheral blood.